Judgment — ECLI:EU:T:2017:491
Date: 2017-07-13
Language of the case: Greek
Court formation: Seventh Chamber
Subject matter: Research and technological development
Procedure: Arbitration clause
Origin: Greece

summary of the pleas in law on which the application based — Plea not supported by precise arguments — Inadmissibility (Statute of the Court of Justice, Arts 21, first para., and 53, first para.; Rules of Procedure of the General Court (1991), Art. 44(1)(c)) (see paras 99, 104) Re: First, application based on Article 272 TFEU seeking a declaration that the expenditure that the applicant declared in the context of grant agreement No 216088 relating to the implementation of the ‘Point-of-care monitoring and diagnostics for autoimmune diseases’ project, concluded in the context of the Seventh Framework Programme for research, technological development and demonstration activities (2007-2013), was eligible and that the request, by the Commission, for recovery of the sum of EUR 273 289.63, pursuant to that grant agreement, amounted to a breach of the Commission’s contractual obligations, as well as, second, a counterclaim seeking an order requiring the applicant to pay the sum of EUR 253 289.63, together with interest and reduced by any later payments. Operative part The Court: 1. Dismisses the action; 2. Orders Talanton AE — Symvouleftiki-Ekpaideftiki Etaireia Dianomon, Parochis Ypiresion Marketing kai Dioikisis Epicheiriseon to reimburse to the European Commission the sum of EUR 253 289.63, paid pursuant to grant agreement No 216088 relating to the implementation of the ‘Point-of-care monitoring and diagnostics for autoimmune diseases’ project, together with late payment interest at the rate of 3.55% from 27 January 2015, reduced by the sum of EUR 5 000 paid to the Commission on 4 May 2015, which is first set against late payment interest and then against the principal amount; 3. Orders Talanton AE — Symvouleftiki-Ekpaideftiki Etaireia Dianomon, Parochis Ypiresion Marketing kai Dioikisis Epicheiriseon to pay the costs.